| Childhood Connective and Soft Tissue Neoplasm studied in …STUDIED_INderived10 of 106show all (up to 200) |
|---|
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 106 trials mapped (17 active) | — | — | Childhood Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07830667Phase 1/Phase 2 · not yet recruiting A Phase 1/2 Study of CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to Treat · condition mapped CURATED_BROADER · 106 trials mapped (17 active) | — | — | Childhood Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06798363Phase 2/Phase 3 · recruiting Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma · condition mapped ONTOLOGY_EXACT · 106 trials mapped (17 active) | — | — | Infantile Hemangioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06789666NA · recruiting Digital Art Therapy for Young Cancer Survivors · condition mapped ALIAS · 106 trials mapped (17 active) | — | — | Childhood Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819838Phase 1/Phase 2 · not yet recruiting Testing the Addition of an Anti-Cancer Drug, Daraxonrasib, for Relapsed or Refractory Solid Tumors With RAS Mutations · condition mapped CURATED_BROADER · 106 trials mapped (17 active) | — | — | Childhood Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06674811recruiting Biomarkers of Resiliency In Childhood Cancer Surgery · condition mapped ONTOLOGY_EXACT · 106 trials mapped (17 active) | — | — | Childhood Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07428993Phase 2 · recruiting Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma · condition mapped ALIAS · 106 trials mapped (17 active) | — | — | Childhood Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · condition mapped ONTOLOGY_EXACT · 106 trials mapped (17 active) | — | — | Childhood Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05857969Phase 1 · recruiting Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling · condition mapped CURATED_BROADER · 106 trials mapped (17 active) | — | — | Childhood Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04539366Phase 1 · suspended Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial · condition mapped CURATED_BROADER · 106 trials mapped (17 active) | — | — | Childhood Osteosarcoma | 1 | Observed | clinicaltrials | graph → |